nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Agonist high- and low-affinity states of dopamine D2 receptors: methods of detection and clinical implications
|
Wieringen, Jan-Peter van |
|
2012 |
386 |
2 |
p. 135-154 |
artikel |
2 |
Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia
|
Sokoloff, Pierre |
|
2012 |
386 |
2 |
p. 107-124 |
artikel |
3 |
Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia
|
Gross, Gerhard |
|
2012 |
386 |
2 |
p. 155-166 |
artikel |
4 |
Interaction of D3 preferring agonist (−)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264) with cloned human D2L, D2S, and D3 receptors: potent stimulation of mitogen-activated protein kinases and G protein-coupled inward rectifier potassium channels
|
Kuzhikandathil, Eldo V. |
|
2012 |
386 |
2 |
p. 97-105 |
artikel |
5 |
Pergolide block of the cloned Kv1.5 potassium channels
|
Jeong, Imju |
|
2012 |
386 |
2 |
p. 125-133 |
artikel |
6 |
Rationale in support of the use of selective dopamine D3 receptor antagonists for the pharmacotherapeutic management of substance use disorders
|
Heidbreder, Christian |
|
2012 |
386 |
2 |
p. 167-176 |
artikel |